Sutton Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-712
| Closed | -$25.4K | – | 1475 |
|
|
2022
Q4 | $25.4K | Hold |
712
| – | – | 0.01% | 600 |
|
|
2022
Q3 | $24.1K | Hold |
712
| – | – | 0.01% | 605 |
|
|
2022
Q2 | $20.6K | Sell |
712
-167
| -19% | -$4.83K | 0.01% | 666 |
|
|
2022
Q1 | $28.4K | Buy |
879
+20
| +2% | +$646 | 0.01% | 597 |
|
|
2021
Q4 | $25K | Buy |
859
+155
| +22% | +$4.52K | 0.01% | 645 |
|
|
2021
Q3 | $18.8K | Hold |
704
| – | – | 0.01% | 709 |
|
|
2021
Q2 | $21.7K | Hold |
704
| – | – | 0.01% | 677 |
|
|
2021
Q1 | $18.4K | Hold |
704
| – | – | 0.01% | 696 |
|
|
2020
Q4 | $17.7K | Hold |
704
| – | – | 0.01% | 653 |
|
|
2020
Q3 | $14.7K | Hold |
704
| – | – | 0.01% | 631 |
|
|
2020
Q2 | $16.7K | Hold |
704
| – | – | 0.01% | 589 |
|
|
2020
Q1 | $12.7K | Sell |
704
-35
| -5% | -$630 | 0.01% | 594 |
|
|
2019
Q4 | $17.5K | Buy |
739
+35
| +5% | +$830 | 0.01% | 653 |
|
|
2019
Q3 | $19.3K | Hold |
704
| – | – | 0.01% | 589 |
|
|
2019
Q2 | $23.3K | Hold |
704
| – | – | 0.01% | 521 |
|
|
2019
Q1 | $24.7K | Sell |
704
-82
| -10% | -$2.87K | 0.01% | 508 |
|
|
2018
Q4 | $26.1K | Buy |
786
+82
| +12% | +$2.72K | 0.02% | 438 |
|
|
2018
Q3 | $35.4K | Hold |
704
| – | – | 0.02% | 384 |
|
|
2018
Q2 | $42.1K | Hold |
704
| – | – | 0.03% | 332 |
|
|
2018
Q1 | $32.2K | Hold |
704
| – | – | 0.02% | 395 |
|
|
2017
Q4 | $28.1K | Hold |
704
| – | – | 0.02% | 437 |
|
|
2017
Q3 | $28.2K | Hold |
704
| – | – | 0.02% | 420 |
|
|
2017
Q2 | $30.3K | Hold |
704
| – | – | 0.02% | 389 |
|
|
2017
Q1 | $22K | Hold |
704
| – | – | 0.02% | 484 |
|
|
2016
Q4 | $17.8K | Hold |
704
| – | – | 0.02% | 533 |
|
|
2016
Q3 | $17.4K | Hold |
704
| – | – | 0.02% | 501 |
|
|
2016
Q2 | $14.3K | Hold |
704
| – | – | 0.01% | 533 |
|
|
2016
Q1 | $10.7K | Buy |
+704
| New | +$10.7K | 0.01% | 595 |
|